Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

EVMU vs. LABD: which is better?

Bottom line

EVMU vs LABD: the short answer

EVMU (Direxion Daily Ether Bull 2X ETF) and LABD (Direxion Daily S&P Biotech Bear 3X ETF) are both etfs.

EVMU is cheaper at 1.03% vs 1.07% — a difference of $4.00 a year per $10,000 invested.

Updated Nov 19, 2026

EVMU vs LABD side by side

EVMULABD
TypeETFETF
Fund familyDirexionDirexion
CategoryLeveraged & InverseLeveraged & Inverse
Expense ratio1.03%1.07%
Annual cost per $10k$103$107
10-yr cost on $10k (prospectus)—$1,316
Max front loadNoneNone
12b-1 fee0%0%
1-yr return—−70.0%
5-yr return (annualized)—−37.7%
10-yr return (annualized)—−54.4%
Best quarter—+75.0%
Worst quarter—−75.2%
Net assets (fund)$2.3M$54.2M
Number of holdings710
Portfolio turnover—%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

7 of EVMU's top 7 holdings also appear in LABD's top 10.

Shared top holdings
HoldingEVMULABD
Goldman Financial52.38%52.74%
Dreyfus28.74%18.03%
Dreyfus21.85%40.47%
N/a3.03%-6.37%
N/a2.73%-6.37%
N/a2.57%-6.37%
N/a-3.06%-6.37%

Source: SEC Form N-PORT

EVMU top 10

  1. Goldman Financial — 52.38%
  2. Dreyfus — 28.74%
  3. Dreyfus — 21.85%
  4. N/a — 3.03%
  5. N/a — 2.73%
  6. N/a — 2.57%
  7. N/a — -3.06%

LABD top 10

  1. Goldman Financial — 52.74%
  2. Dreyfus — 40.47%
  3. Goldman Sachs Liq Es Fd A — 26.30%
  4. Dreyfus — 18.03%
  5. N/a — 2.98%
  6. N/a — 1.43%
  7. N/a — -1.55%
  8. N/a — -4.11%
  9. N/a — -4.88%
  10. N/a — -6.37%

FAQ

What is the difference between EVMU and LABD?
EVMU (Direxion Daily Ether Bull 2X ETF) and LABD (Direxion Daily S&P Biotech Bear 3X ETF) are both etfs. EVMU is cheaper at 1.03% vs 1.07% — a difference of $4.00 a year per $10,000 invested.
Which is cheaper, EVMU or LABD?
EVMU has the lower expense ratio (1.03%).
Should I own both EVMU and LABD?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.